CONMED Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2074101013
USD
44.24
-0.11 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About CONMED Corp. stock-summary
stock-summary
CONMED Corp.
Pharmaceuticals & Biotechnology
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company's product lines consist of orthopedic surgery and general surgery.
Company Coordinates stock-summary
Company Details
525 French Road , UTICA NY : 13502
stock-summary
Tel: 1 315 79783751 315 6243317
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 100 Schemes (65.76%)

Foreign Institutions

Held by 124 Foreign Institutions (10.95%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
343 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,777 Million (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

138.36%

stock-summary
Debt Equity

0.85

stock-summary
Return on Equity

8.88%

stock-summary
Price to Book

1.77